KAREN STENTZ: Open Payments
NPI 1578753224 · AZLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 31 payments from 9 companies in 2025. Trend: 2023 $1,214 · 2024 $659 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $190 |
| ABBVIE INC. | 9 | $169 |
| Corcept Therapeutics | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Lilly USA, LLC | 2 | $46 |
| Amgen Inc. | 2 | $28 |
| Abbott Laboratories | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Ozempic, Korlym, VRAYLAR, UBRELVY, Wegovy, Rybelsus, AIRSUPRA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
